Exor N.V. holds a concentrated book of 3 reported positions worth $5.4B as of Q1 2026 (disclosed May 13, 2026, a ~43-day 13F lag). The SEC 13F shows only Exor N.V.'s US-listed positions. Its main portfolio is mostly Amsterdam/Milan-listed and does not appear in this book. Their largest long position is Koninklijke Philips N V at 93% of the reported non-option book. Cloning the disclosed picks since 2023 would be -81% (-37.3%/yr). That is a simulation of the disclosed long book, not audited returns.
The reported book (valued from quarter-end) returned -77.9%, a 3.3-point gap that is the cost of the ~43-day 13F disclosure lag a real follower can't avoid.
Growth of $10,000 cloning Exor N.V.'s disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~43 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: concentrated book
Excluding Koninklijke Philips N V (93% of the book), the rest is a concentrated book:
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
7% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Other tracked managers holding the same core names as Exor N.V.
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| XTX Topco Ltd | 2 / 3 | $5.2M |
| Quantbot Technologies LP | 2 / 3 | $1.7M |
| Quent Capital, LLC | 2 / 3 | $585K |
| Oppenheimer & Co Inc | 2 / 3 | $2.7M |
| Renaissance Technologies LLC | 2 / 3 | $6.1M |
| Principal Financial Group Inc | 2 / 3 | $16.3M |
| Balyasny Asset Management L.P. | 2 / 3 | $6.4M |
| Janus Henderson Group Ltd. | 2 / 3 | $13.2M |
Ranked by the share of each fund's own book sitting in the names it shares with Exor N.V.: only funds sharing at least a tenth of the book qualify. Index giants, bank custody books and market makers are excluded. They hold everything, so their overlap says nothing.
Bars show each position's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Koninklijke Philips N V NY REGIS SHS NEW | $5.0B | 182.54M | 92.9% | —Held | |
| 2 | Via Transn Inc COM CL A | $211.8M | 14.12M | 3.9% | —Held | |
| 3 | Clarivate PLC ORD SHS | $170.3M | 67.29M | 3.2% | —Held |
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1589122/holdings"
Use Arkolith to show Exor N.V.'s latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
Reported 13F total per quarter, log scale (the range spans more than 20x). Raw filing totals can include option notional.
| Quarter | As of | Filed | Lag | Positions | Value | Form |
|---|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 13, 2026 | 43d | 3 | $5.4B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 3, 2026 | 34d | 3 | $5.6B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 12, 2025 | 43d | 3 | $5.9B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Jul 16, 2025 | 16d | 2 | $4.7B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 8, 2025 | 38d | 2 | $4.7B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Jan 22, 2025 | 22d | 2 | $4.5B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Oct 17, 2024 | 17d | 2 | $5.9B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Jul 9, 2024 | 9d | 2 | $4.5B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | Apr 16, 2024 | 16d | 2 | $3.3B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 12, 2024 | 43d | 2 | $3.9B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 8, 2023 | 39d | 2 | $3.0B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 | 45d | 2 | $905.4M | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 15, 2023 | 45d | 1 | $304.9M | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 14, 2023 | 45d | 1 | $139.0M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. Book totals and portfolio weights cover reported non-option positions, which can include notes and warrants. Disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.